Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2021-01-15 Sale |
2021-01-19 4:05 pm |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
2,500 | $53.15 | $132,875 | 826,523 (Indirect Direct) |
View |
2021-01-14 Sale |
2021-01-15 4:10 pm |
Apellis Pharmaceuticals Inc. | APLS | Grossi Federico CHIEF MEDICAL OFFICER |
4,000 | $51.99 | $207,960 | 35,827 (Direct) |
View |
2021-01-04 Sale |
2021-01-05 4:21 pm |
Apellis Pharmaceuticals Inc. | APLS | Grossi Federico CHIEF MEDICAL OFFICER |
600 | $57.24 | $34,344 | 39,827 (Direct) |
View |
2021-01-04 Sale |
2021-01-05 4:20 pm |
Apellis Pharmaceuticals Inc. | APLS | Perry Nicole D Vice President - Accounting |
2,000 | $57.24 | $114,480 | 15,161 (Direct) |
View |
2020-12-15 Sale |
2020-12-16 4:36 pm |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
2,500 | $52.16 | $130,400 | 829,023 (Indirect Direct) |
View |
2020-12-15 Sale |
2020-12-16 4:35 pm |
Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer |
5,000 | $52.16 | $260,800 | 1,347,490 (Indirect Direct) |
View |
2020-12-14 Sale |
2020-12-15 5:05 pm |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
25,000 | $54.67 | $1,366,713 | 174,728 (Indirect) |
View |
2020-12-11 Sale |
2020-12-15 4:03 pm |
Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel |
18,333 | $50.94 | $933,947 | 105,136 (Indirect Direct) |
View |
2020-12-04 Sale |
2020-12-08 7:32 pm |
Apellis Pharmaceuticals Inc. | APLS | Perry Nicole D Vice President - Accounting |
18,000 | $50 | $900,000 | 17,161 (Direct) |
View |
2020-12-04 Sale |
2020-12-07 6:58 pm |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
25,000 | $50.59 | $1,264,854 | 199,728 (Indirect) |
View |
2020-12-01 Sale |
2020-12-02 4:30 pm |
Apellis Pharmaceuticals Inc. | APLS | Grossi Federico CHIEF MEDICAL OFFICER |
600 | $48.25 | $28,950 | 33,177 (Direct) |
View |
2020-11-16 Sale |
2020-11-17 7:13 pm |
Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer |
5,000 | $39.38 | $196,900 | 1,312,490 (Indirect Direct) |
View |
2020-11-16 Sale |
2020-11-17 7:12 pm |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
2,500 | $39.38 | $98,450 | 831,523 (Indirect Direct) |
View |
2020-11-02 Sale |
2020-11-03 4:01 pm |
Apellis Pharmaceuticals Inc. | APLS | Grossi Federico CHIEF MEDICAL OFFICER |
600 | $31.09 | $18,654 | 27,725 (Direct) |
View |
2020-10-15 Sale |
2020-10-16 5:56 pm |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
2,500 | $35 | $87,500 | 834,023 (Indirect Direct) |
View |
2020-10-15 Sale |
2020-10-16 5:31 pm |
Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer |
5,000 | $34.46 | $172,300 | 1,317,490 (Indirect Direct) |
View |
2020-10-07 Sale |
2020-10-09 4:48 pm |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
7,500 | $35 | $262,500 | 836,523 (Indirect Direct) |
View |
2020-10-07 Sale |
2020-10-09 4:45 pm |
Apellis Pharmaceuticals Inc. | APLS | Brown Victoria L. Program Team Lead |
12,000 | $35 | $420,000 | 42,875 (Direct) |
View |
2020-10-01 Sale |
2020-10-02 4:14 pm |
Apellis Pharmaceuticals Inc. | APLS | Grossi Federico See Remarks |
600 | $30.22 | $18,132 | 28,325 (Direct) |
View |
2020-09-15 Sale |
2020-09-16 4:03 pm |
Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer |
5,000 | $30.96 | $154,800 | 1,322,490 (Indirect Direct) |
View |
2020-09-01 Sale |
2020-09-02 4:36 pm |
Apellis Pharmaceuticals Inc. | APLS | Grossi Federico See Remarks |
600 | $31.58 | $18,948 | 28,925 (Direct) |
View |
2020-08-20 Sale |
2020-08-21 4:36 pm |
Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer |
3,457 | $30 | $103,710 | 1,327,490 (Indirect Direct) |
View |
2020-08-18 Sale |
2020-08-20 4:45 pm |
Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer |
1,543 | $30 | $46,290 | 1,330,947 (Indirect Direct) |
View |
2020-08-03 Sale |
2020-08-05 4:37 pm |
Apellis Pharmaceuticals Inc. | APLS | Grossi Federico See Remarks |
600 | $26.28 | $15,768 | 29,525 (Direct) |
View |
2020-07-15 Sale |
2020-07-16 4:07 pm |
Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer |
5,000 | $32.12 | $160,600 | 1,332,490 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2021-01-27 Exercise |
2021-01-29 4:19 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer |
31,992 | $4.31 | 2,083,055 (Direct) |
View |
2021-01-27 Exercise |
2021-01-29 4:19 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer |
39,785 | $3.76 | 2,083,055 (Direct) |
View |
2021-01-27 Exercise |
2021-01-29 4:19 pm |
N/A 2026-02-06 |
Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer |
71,777 | $0 | 2,083,055 (Direct) |
View |
2021-01-27 Exercise |
2021-01-29 4:18 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel |
20,042 | $4.31 | 100,286 (Direct) |
View |
2021-01-27 Exercise |
2021-01-29 4:18 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel |
23,441 | $3.76 | 100,286 (Direct) |
View |
2021-01-27 Exercise |
2021-01-29 4:18 pm |
N/A 2026-02-06 |
Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel |
43,483 | $0 | 100,286 (Direct) |
View |
2021-01-25 Exercise |
2021-01-26 4:25 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Grossi Federico CHIEF MEDICAL OFFICER |
11,500 | $3.76 | 113,561 (Direct) |
View |
2021-01-25 Exercise |
2021-01-26 4:25 pm |
N/A 2024-12-12 |
Apellis Pharmaceuticals Inc. | APLS | Grossi Federico CHIEF MEDICAL OFFICER |
15,000 | $0 | 113,561 (Direct) |
View |
2021-01-25 Exercise |
2021-01-26 4:25 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Grossi Federico CHIEF MEDICAL OFFICER |
3,500 | $3.2 | 113,561 (Direct) |
View |
2021-01-15 Exercise |
2021-01-19 4:05 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
2,500 | $2.67 | 826,523 (Direct) |
View |
2021-01-15 Exercise |
2021-01-19 4:05 pm |
N/A 2023-12-04 |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
2,500 | $0 | 826,523 (Direct) |
View |
2021-01-04 Exercise |
2021-01-05 4:20 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Perry Nicole D Vice President - Accounting |
2,000 | $3.76 | 15,161 (Direct) |
View |
2021-01-04 Exercise |
2021-01-05 4:20 pm |
N/A 2025-07-31 |
Apellis Pharmaceuticals Inc. | APLS | Perry Nicole D Vice President - Accounting |
2,000 | $0 | 15,161 (Direct) |
View |
2021-01-01 Option Award |
2021-01-04 7:31 pm |
N/A 2030-12-31 |
Apellis Pharmaceuticals Inc. | APLS | FONTEYNE PAUL R. Director |
27,600 | $0 | 27,600 (Direct) |
View |
2021-01-01 Option Award |
2021-01-04 7:26 pm |
N/A 2030-12-31 |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
27,600 | $0 | 27,600 (Direct) |
View |
2021-01-01 Option Award |
2021-01-04 7:25 pm |
N/A 2030-12-31 |
Apellis Pharmaceuticals Inc. | APLS | Chan Gerald Director |
27,600 | $0 | 27,600 (Direct) |
View |
2021-01-01 Option Award |
2021-01-04 7:21 pm |
N/A 2030-12-31 |
Apellis Pharmaceuticals Inc. | APLS | O'Brien Stephanie Monaghan Director |
27,600 | $0 | 27,600 (Direct) |
View |
2021-01-01 Option Award |
2021-01-04 7:19 pm |
N/A 2030-12-31 |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
27,600 | $0 | 27,600 (Direct) |
View |
2020-12-23 Option Award |
2020-12-23 5:41 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Eisele Jeffrey Exec VP, Program Team Lead |
1,211 | $0 | 1,211 (Direct) |
View |
2020-12-15 Exercise |
2020-12-16 4:36 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
2,500 | $2.67 | 829,023 (Direct) |
View |
2020-12-15 Exercise |
2020-12-16 4:36 pm |
N/A 2023-12-04 |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
2,500 | $0 | 829,023 (Direct) |
View |
2020-12-11 Exercise |
2020-12-15 4:03 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel |
18,333 | $13.85 | 105,136 (Direct) |
View |
2020-12-11 Exercise |
2020-12-15 4:03 pm |
N/A 2029-02-07 |
Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel |
18,333 | $0 | 105,136 (Direct) |
View |
2020-12-08 Exercise |
2020-12-09 5:34 pm |
N/A 2028-04-12 |
Apellis Pharmaceuticals Inc. | APLS | SCHEIBLER LUKAS CHIEF INNOVATION OFFICER |
7,482 | $0 | 158,113 (Direct) |
View |
2020-12-08 Exercise |
2020-12-09 5:34 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | SCHEIBLER LUKAS CHIEF INNOVATION OFFICER |
7,482 | $26.73 | 158,113 (Direct) |
View |
2020-12-04 Exercise |
2020-12-08 7:32 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Perry Nicole D Vice President - Accounting |
18,000 | $3.76 | 17,161 (Direct) |
View |
2020-12-04 Exercise |
2020-12-08 7:32 pm |
N/A 2025-07-31 |
Apellis Pharmaceuticals Inc. | APLS | Perry Nicole D Vice President - Accounting |
18,000 | $0 | 17,161 (Direct) |
View |
2020-12-04 Exercise |
2020-12-08 7:21 pm |
N/A 2024-12-12 |
Apellis Pharmaceuticals Inc. | APLS | Grossi Federico CHIEF MEDICAL OFFICER |
7,250 | $0 | 83,000 (Direct) |
View |
2020-12-04 Exercise |
2020-12-08 7:21 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Grossi Federico CHIEF MEDICAL OFFICER |
7,250 | $3.2 | 83,000 (Direct) |
View |
2020-12-01 Exercise |
2020-12-02 4:31 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer |
40,000 | $3.76 | 1,666,115 (Direct) |
View |
2020-12-01 Exercise |
2020-12-02 4:31 pm |
N/A 2026-02-07 |
Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer |
40,000 | $0 | 1,666,115 (Direct) |
View |
2020-11-16 Exercise |
2020-11-17 7:12 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
2,500 | $2.67 | 831,523 (Direct) |
View |
2020-11-16 Exercise |
2020-11-17 7:12 pm |
N/A 2023-12-04 |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
2,500 | $0 | 831,523 (Direct) |
View |
2020-11-16 Exercise |
2020-11-17 7:11 pm |
N/A 2024-12-11 |
Apellis Pharmaceuticals Inc. | APLS | Grossi Federico CHIEF MEDICAL OFFICER |
5,750 | $0 | 83,600 (Direct) |
View |
2020-11-16 Exercise |
2020-11-17 7:11 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Grossi Federico CHIEF MEDICAL OFFICER |
5,750 | $3.2 | 83,600 (Direct) |
View |
2020-10-15 Exercise |
2020-10-16 5:56 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
2,500 | $2.67 | 834,023 (Direct) |
View |
2020-10-15 Exercise |
2020-10-16 5:56 pm |
N/A 2023-12-04 |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
2,500 | $0 | 834,023 (Direct) |
View |
2020-10-07 Exercise |
2020-10-09 4:48 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
7,500 | $2.67 | 836,523 (Direct) |
View |
2020-10-07 Exercise |
2020-10-09 4:48 pm |
N/A 2023-12-04 |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
7,500 | $0 | 836,523 (Direct) |
View |
2020-10-07 Exercise |
2020-10-09 4:45 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Brown Victoria L. Program Team Lead |
12,000 | $18.98 | 42,875 (Direct) |
View |
2020-10-07 Exercise |
2020-10-09 4:45 pm |
N/A 2029-03-06 |
Apellis Pharmaceuticals Inc. | APLS | Brown Victoria L. Program Team Lead |
12,000 | $0 | 42,875 (Direct) |
View |
Ownership |
2020-10-06 4:39 pm |
N/A 2030-08-16 |
Apellis Pharmaceuticals Inc. | APLS | Nicholson Nur Chief Technical Officer |
0 | $0 | 125,000 (Direct) |
View |
Ownership |
2020-10-06 4:37 pm |
N/A 2030-08-31 |
Apellis Pharmaceuticals Inc. | APLS | Eisele Jeffrey See Remarks |
0 | $0 | 125,000 (Direct) |
View |